Brief: Innocan To Focus Development Resources On Advancing Its Lpt-Cbd, A Monthly Injectable Treatment For Chronic Pain In Both Animals And Humans
11/11/2024 21:46
Nov 11 (Reuters) - Innocan Pharma Corp INNO.CD :
* INNOCAN : TO FOCUS DEVELOPMENT RESOURCES ON ADVANCING ITS
LPT-CBD, A MONTHLY INJECTABLE TREATMENT FOR CHRONIC PAIN IN BOTH
ANIMALS AND HUMANS
Source text: ID:nCNWWPglTa
Further company coverage: INNO.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innocan Pharma
See all newsBrief: Innocan Pharma Corp To Offer Up To 3.75 Million Units In IPO - SEC Filing
Brief: Innocan Pharma Announces Promising Results Of LPT-CBD Administered To Gottingen Minipigs
Brief: Innocan Pharma Corp - Liposomal Cbd Injection Technology Patent Allowed In Japan
Brief: Innocan Pharma Corp Now Sees U.S IPO Of 1.1 Million Units - SEC Filing
Brief: Innocan Pharma Announces Details Of Proposed Share Consolidation